Cipla to see growth of 14% this year: Chairman

Drugmaker Cipla expects to meet domestic industry growth of 14% this year, its chairman said on Thursday, but warned of a possible slowdown in its business in Libya, Syria and Algeria due to the political situation in those nations.

August 25, 2011 / 18:46 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Drugmaker Cipla expects to meet domestic industry growth of 14% this year, its chairman said on Thursday, but warned of a possible slowdown in its business in Libya, Syria and Algeria due to the political situation in those nations.

"There has not been major impact on the overall Africa business but only certain countries have slowdown due to the political situation in the last year," Yusuf Hamied told an annual meeting of shareholders.

The Mumbai-based firm, which enjoys the highest share in India's pharmaceuticals market, is known for selling low-cost generic versions of anti-retroviral drugs used to fight HIV/AIDS.

first published: Aug 25, 2011 04:51 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347